Topics

Companies Related to "Democrat Presidential Candidates pledge lower drug prices without" [Most Relevant Company Matches] [Advanced Search Results] RSS

13:39 EDT 5th April 2020 | BioPortfolio

Here are the most relevant search results for "Democrat Presidential Candidates pledge lower drug prices without" found in our extensive corporate database of over 50,000 company records.

Showing "Democrat Presidential Candidates pledge lower drug prices without" Companies 1–25 of 4,800+

Relevant

Ohio Taxpayers for Lower Drug Prices


Triangle Pharmaceuticals Incorporated

Triangle Pharmaceuticals develop new drug candidates primarily in the antiviral area, with a particular focus on therapies for HIV, including AIDS, and the hepatitis B virus ("HBV"). Triangle Pharmaceuticals have an existing portfolio of six licensed drug candidates and one drug candidate for which they have an option to acquire a license. Five of these drug candidates are currently under active d...

Smartchoicedrugstore

SmartChoiceDrugStore (SCD) implements an unparalleled wholesale pricing model, which is completely new for the retail pharmacy industry and introduces prices discounted below SCD’s normal retail pricing. The Club is priced substantially lower than any other discount, prescription drug program as a way of meeting the demands of the underinsured, uninsured and businesses who continue to be devasta...


GENEQ inc.

GENEQ inc. has been a leading supplier of testing and measuring instruments for over 30 years. We built our reputation by supplying our customers with high quality products and services. With five (5) distinct departments, we are well prepared in assisting you with application and product selection questions. Offering the finest products available at reasonable prices is only the beginning of our ...

Blink Health

Founded in 2014, Blink Health is a technology platform that enables consumers to access the medications they need at prices they can afford at over 57,000 pharmacies nationwide. Blink’s free mobile app and website allow users to purchase their medications online and pick them up at their local retailer for up to 90% off the average retail price. Blink...

Blink Health Blink Health

Founded in 2014, Blink Health is a technology platform that enables consumers to access the medications they need at prices they can afford at over 40,000 pharmacies nationwide. Blink’s website and free mobile app allow users to purchase their medications online and pick them up at their local retailer for up to 95% off the average retail price. Blink ...

Sequent Development LLC

Sequent Development LLC provides high quality, low cost pre-clinical drug development services to the biopharmaceutical industry. Our principal services are screening of new drug candidates for specific pharmacological activity, pharmacological safety studies, and conduct of acute toxicity studies required by regulatory authorities in order to begin testing new drug candidates in man. We are able ...

Action Pharma

Action Pharma is a privately owned Danish biotech company. The main strategy of Action Pharma is to develop novel drug candidates targeting melanocortin receptors and bring these to clinical proof of concept for subsequent partnering. The drug candidates are first in class and exploit novel mode of action profiles with efficacy that is superior compared to the current market. Action Pharma has...

Takeda San Diego

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer. Multiple drug candidates discovered at TSD are currently in clinical trials including SYR322, a pot...

Heptares Therapeutics Ltd

Heptares discovers and develops new medicines targeting GPCRs (G-protein-coupled receptors), a super-family of drug targets linked to a wide range of human diseases. We have established R&D collaborations with Shire, Takeda, AstraZeneca, Medimmune, and Novartis Option Fund, and have raised $40 million in venture financing from MVM Life Science Partners, Clarus Ventures, Novartis Venture Fu...

Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. Our proprietary drug candidates are designed to modulate specific Toll-like Receptors, which are a family of immune system receptors that direct immune system responses. Our p...

DARA BioSciences, Inc.

DARA BioSciences, Inc. is a Raleigh, North Carolina based development-stage biopharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND’s (Investigationa...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product candidates to market, it also believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its...

Ron Paul 2012 Presidential Campaign Committee

Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. Our proprietary drug candidates are designed to modulate specific Toll-like Receptors, which are a family of immune system receptors that direct immune system responses. Our p...

Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidates in clinical development are Telintra, a modified glutathione analog for the treatment of MDS and Severe Chronic Neutropenia (SCN), and Telcyta®, a cancer activated prodrug for the treatment of advanced n...

GlycoGenesys Incorporated

GlycoGenesys, Inc. is a biotechnology company developing novel drug candidates primarily based on glycobiology. Our product development strategy focuses on therapeutic applications where there is an unmet medical need for life threatening or debilitating diseases. The company's lead drug candidate, GCS-100, formerly known as GBC-590, is a potential treatment for multiple forms of cancer. We plan t...

DOV Pharmaceutical, Inc

DOV Pharmaceutical, Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, or CNS, disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, pain and depression.DOV currently has three product candidates in various stages of clinica...

Synta Pharmaceuticals

Synta Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing products for extending and enhancing the lives of patients with severe medical conditions. We have a diverse pipeline of novel, small-molecule drug candidates targeting major unmet needs in large therapeutic markets, including chronic inflammatory diseases and cancers. All clinical candidat...

vTv Therapeutics, Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv Therapeutics has a pipeline of clinical drug candidates for the treatment of Alzheimer’s disease, diabetes, inflammatory disorders and the pre...

Ohioans for Fair Drug Prices

VistaGen Therapeutics, Inc.

VistaGen Therapeutics is a biotechnology company focused on using proprietary pluripotent stem cell technology to discover, rescue and develop novel drug candidates for a broad range of diseases and conditions. VistaGen’s integrated stem cell technology platform, Human Clinical Trials in a Test Tube™, is based on the differentiation of human plur...

Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in other major therapeutic areas. Clinical Data combines its drug development and biomarker expertise in an effort to d...

The Georgia Prostate Cancer Pledge Committee

vTv Therapeutics LLC

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of in...


More From BioPortfolio on "Democrat Presidential Candidates pledge lower drug prices without"

Quick Search

Corporate Database Quicklinks